Propranolol Extended-Release Capsules 60 mg, 80 mg, 120 mg, 160 mg Suppliers & Bulk Manufacturers
Available Forms: Extended-Release Capsules
Available Strengths: 60 mg, 80 mg, 120 mg, 160 mg
Reference Brands: Inderal LA®
Category: Antipsychotropic Drugs
Propranolol is a non-selective beta-adrenergic blocker that inhibits β1 and β2 receptors, reducing heart rate, cardiac output, and blood pressure. It decreases sympathetic nervous system activity, making it effective for hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. The extended-release (ER) capsules provide a steady release over 24 hours, improving compliance and maintaining consistent blood levels. Propranolol ER is also used off-label for performance anxiety and PTSD symptoms.
Product Description: Propranolol Extended-Release (ER) capsules are FDA-approved in the U.S. for treating hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. As a non-selective beta-blocker, it is subject to cardiovascular safety labeling, and extended-release formulations must meet modified-release and bioequivalence standards. U.S. regulations require GMP-compliant manufacturing, stability data, and ongoing pharmacovigilance. In the European Union, propranolol ER is authorized for similar indications under national approvals, with adherence to EMA guidance on beta-blockers. EU-specific requirements include Risk Management Plans (RMPs) and post-marketing surveillance. For dossier-ready Propranolol ER capsules, visit Pharmatradz.com.
Propranolol Extended-Release Capsules — third party manufacturing & bulk supply
Propranolol Extended-Release Capsules 60 mg, 80 mg, 120 mg, 160 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Propranolol Extended-Release Capsules is supplied as Extended-Release Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Propranolol Extended-Release Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Propranolol Extended-Release Capsules →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
